posted
ADVANCED VIRAL RESEARCH INC (U-ADVR) - News Release Advanced Viral Research (ADVR) is Granted US Patent for Rheumatoid Arthritis
2006-07-17 12:26 ET - News Release
YONKERS, N.Y. -- (Business Wire) -- July 17, 2006
Advanced Viral Research Corp. (OTC Bulletin Board: ADVR) a bio-pharmaceutical company, announced today that effective June 27, 2006, the company has received US patent approval for treatment of rheumatoid arthritis by administering Product R (AVR118), a peptide-nucleic acid preparation. Rheumatoid arthritis, a chronic inflammatory illness, is an autoimmune disease in which the immune system attacks normal tissue components as if they were invading pathogens. This illness affects about one percent of the world's population. "We are excited that the US Patent Office has granted us with this important patent," says Stephen M. Elliston, CEO and President of Advanced Viral Research. "With such a large population affected by rheumatoid arthritis, the commercial prospects for AVR118 may potentially be expanded to include patients suffering from this debilitating disease. This also comes at a time when the treatment options for RA have been limited significantly by the withdrawal of COX II inhibitors from the market." Advanced Viral Research Corp., based in Yonkers, New York, is a biopharmaceutical firm dedicated to improving patients' lives by researching, developing and bringing to market new and effective therapies for viral and other diseases. ADVR's lead product, AVR118 (formerly known as Product R), represents a complex mixture of peptides, amino acids, nucleosides, nucleotides and nucleic acid bases that possesses, among other things, immunomodulatory activity. We believe it may be employed in the treatment of diseases and conditions such as: Various conditions associated with cancer; cachexia, or body wasting, in patients with acquired immune deficiency syndrome (AIDS), cancer, human immunodeficiency virus, or HIV, including AIDS as a combination therapy; type 2 diabetes; human papilloma virus, or HPV; and rheumatoid arthritis. ADVR is in clinical trials for treatment of cachexia (body wasting) in patients with AIDS.
Note: This news release contains forward-looking statements that involve risks associated with clinical development, regulatory approvals, including application to the FDA, product commercialization and other risks described From time to time in the SEC reports filed by the Company. AVR118 (Product R) is not approved by the U.S. Food and Drug Administration or any comparable Agencies of any other countries. There is no assurance that the Company will be able to secure the financing necessary to continue and/or complete the clinical trials of AVR118 or satisfy certain other conditions relating to clinical trials including obtaining adequate insurance on terms acceptable to the Company or that if completed, clinical trials performed outside the United States will assist the Company in obtaining FDA or other regulatory approval. The Company undertakes no obligation to update or revise the information contained in this announcement whether as a result of new information, future Events or circumstances or otherwise.
For further information regarding Advanced Viral Research Corp., please Visit our website at http://www.adviral.com. Contacts:
Equity Relations, Inc. Richard Brown, 617-314-7379 staff*equityrelations.com
Posts: 5120 | Registered: Jun 2004
| IP: Logged |
posted
gonna surge again, finally fill at 8 and 85
-------------------- Choosing individual stocks without any idea of what you're looking for (or without reliable information) is like running through a dynamite factory with a burning match. You may live, but your still an idiot. Posts: 5320 | From: Syracuse, NY | Registered: Apr 2005
| IP: Logged |
-------------------- Choosing individual stocks without any idea of what you're looking for (or without reliable information) is like running through a dynamite factory with a burning match. You may live, but your still an idiot. Posts: 5320 | From: Syracuse, NY | Registered: Apr 2005
| IP: Logged |
posted
not many have seen the news yet, after lunch will tell the tale
-------------------- Choosing individual stocks without any idea of what you're looking for (or without reliable information) is like running through a dynamite factory with a burning match. You may live, but your still an idiot. Posts: 5320 | From: Syracuse, NY | Registered: Apr 2005
| IP: Logged |
posted
thoughts Prd, looks like its taking a breather to me
-------------------- Choosing individual stocks without any idea of what you're looking for (or without reliable information) is like running through a dynamite factory with a burning match. You may live, but your still an idiot. Posts: 5320 | From: Syracuse, NY | Registered: Apr 2005
| IP: Logged |
posted
One percent of the global population?does anyone have any numbers in terms if revenue...?
Advanced Viral Research Corp. (OTC Bulletin Board: ADVR - News) a bio-pharmaceutical company, announced today that effective June 27, 2006, the company has received US patent approval for treatment of rheumatoid arthritis by administering Product R (AVR118), a peptide-nucleic acid preparation. Rheumatoid arthritis, a chronic inflammatory illness, is an autoimmune disease in which the immune system attacks normal tissue components as if they were invading pathogens. This illness affects about one percent of the world's population.
-------------------- pennies rock...but only brav hearts allowed here Posts: 575 | From: seattle | Registered: Oct 2005
| IP: Logged |
posted
man i want to throw more at this, does anyone else feel like this is a steal?
-------------------- Choosing individual stocks without any idea of what you're looking for (or without reliable information) is like running through a dynamite factory with a burning match. You may live, but your still an idiot. Posts: 5320 | From: Syracuse, NY | Registered: Apr 2005
| IP: Logged |
posted
I'm watching it and think it is a steal too...but remember..it's not FDA approved yet...that could/usually takes years with numerous VERY EXPENSIVE trials...not bashing..just my two cents...
-------------------- I teach in the middle of a cornfield-Do your own DD and don't base your investments on my opinions Posts: 599 | From: AmishLand, PA | Registered: Jan 2006
| IP: Logged |
posted
true, but the patent is the biggest thing to ever happen to this co it looks like, and they are trading at nearly a two year low, makes me think this has to have some legs this afternoon and tomorrow
-------------------- Choosing individual stocks without any idea of what you're looking for (or without reliable information) is like running through a dynamite factory with a burning match. You may live, but your still an idiot. Posts: 5320 | From: Syracuse, NY | Registered: Apr 2005
| IP: Logged |
posted
nice call PRD this will test .10 this afternoon from the looks of the movement!
Posts: 3346 | From: Leominster,MA,US | Registered: Jul 2003
| IP: Logged |
posted
nice to see you here rick, Im astonished its not there yet, i like the support though, the PM and eod should see some nice green
-------------------- Choosing individual stocks without any idea of what you're looking for (or without reliable information) is like running through a dynamite factory with a burning match. You may live, but your still an idiot. Posts: 5320 | From: Syracuse, NY | Registered: Apr 2005
| IP: Logged |
-------------------- Choosing individual stocks without any idea of what you're looking for (or without reliable information) is like running through a dynamite factory with a burning match. You may live, but your still an idiot. Posts: 5320 | From: Syracuse, NY | Registered: Apr 2005
| IP: Logged |
-------------------- Choosing individual stocks without any idea of what you're looking for (or without reliable information) is like running through a dynamite factory with a burning match. You may live, but your still an idiot. Posts: 5320 | From: Syracuse, NY | Registered: Apr 2005
| IP: Logged |
posted
I'm guessing very strong last hour run that could break the .10 wall and a gap to .12 or so pre market then maybe .18-.19 after that! Thios looks poised for a very nice ride!
-------------------- Nothing moves a sub like news!!! Posts: 3346 | From: Leominster,MA,US | Registered: Jul 2003
| IP: Logged |
posted
lets hope so, bought a little more at .078, couldnt resist
-------------------- Choosing individual stocks without any idea of what you're looking for (or without reliable information) is like running through a dynamite factory with a burning match. You may live, but your still an idiot. Posts: 5320 | From: Syracuse, NY | Registered: Apr 2005
| IP: Logged |
posted
oh, im not selling till .10-.11 atleast, I have another order in for .07 if she decides to go that low. Looking for that gapper tomorrow, then sell her off
-------------------- Choosing individual stocks without any idea of what you're looking for (or without reliable information) is like running through a dynamite factory with a burning match. You may live, but your still an idiot. Posts: 5320 | From: Syracuse, NY | Registered: Apr 2005
| IP: Logged |
posted
as per the 10k ADVC is 41% owned by insiders
-------------------- Choosing individual stocks without any idea of what you're looking for (or without reliable information) is like running through a dynamite factory with a burning match. You may live, but your still an idiot. Posts: 5320 | From: Syracuse, NY | Registered: Apr 2005
| IP: Logged |
posted
boy they are taking turns controlling the b/a, first it was nite, then ubss, now tdcm lol
-------------------- Choosing individual stocks without any idea of what you're looking for (or without reliable information) is like running through a dynamite factory with a burning match. You may live, but your still an idiot. Posts: 5320 | From: Syracuse, NY | Registered: Apr 2005
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
